# US 2015/0102099 A1 · Uniquely identifiable drug dosage form units

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0102099 A1
- Document ID: US20150102099A1
- Status: Published application
- Kind: A1
- Application number: 14/517,737
- Filed: 2014-10-17
- Published: 2015-04-16
- Earliest claimed: 2013-04-12
- Inventors: David Prokop
- Web page: https://patentgrep.com/patent/US20150102099A1

## CPC

- G16H 40/20: for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
- A61J 1/03: for pills or tablets (containers for pills or tablets with special dispensing means therefor B65D83/04)
- A61J 3/007: {Marking tablets or the like (apparatus for printing on tablets or the like B41F17/36)}
- B41F 17/38: for printing on knitted fabrics
- G06K 19/086: {with markings consisting of randomly placed or oriented elements, the randomness of the elements being useable for generating a unique identifying signature of the record carrier, e.g. randomly placed magnetic fibers or magnetic particles in the body of a credit card}
- G06K 19/14: the marking being sensed by radiation
- G06V 20/66: Trinkets, e.g. shirt buttons or jewellery items (recognising microscopic objects G06V20/69)
- G06V 20/80: Recognising image objects characterised by unique random patterns
- G16H 20/13: delivered from dispensers
- A61J 2205/00: General identification or selection means
- A61J 2205/30: Printed labels
- G06V 20/95: {Pattern authentication; Markers therefor; Forgery detection}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- B41F: PRINTING MACHINES OR PRESSES (manifolding devices or office printing machines B41L)
- G06K: GRAPHICAL DATA READING (image or video recognition or understanding G06V); PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06V: IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING

## Abstract

The present invention provides products, systems, and methods for the unique identification of individual drug dosage form units. The invention includes: random integrated optical identification marking of an individual drug unit; a lack of direct surface-to-surface contact between a marking instrument and the drug unit, i.e., deposition of a mark; drug unit image data based on the identification mark; a secondary product identifier associated with the individual drug unit; and comparing the marked drug unit to drug unit image data.

## Claims

### Claim at position 1

-30. (canceled)

### Claim 31

A drug unit authentication system, comprising a plurality of drug units, each drug unit containing a drug common to the plurality of drug units, and each drug unit having a deposited random integrated optically identifiable marking on a surface of or within a drug unit, wherein the marking of each drug unit in the plurality of drug units has a size, shape, location or distribution unique and differentiatable from the markings of all other of the drug units in the plurality of drug units, wherein each drug unit in the plurality of drug units has a secondary product identifier common to the plurality of the drug units and related to the common drug of the plurality of drug units, wherein the marking is configured for use in a comparison of a selected one of the drug units and drug unit marking data associated with the selected one of the drug units and being related to the markings and the second product identifier for the selected one of the drug units.

### Claim 32 (depends on 31)

The system of claim 31 wherein the deposited random integrated optically identifiable marking includes one or more of dots, spots, shapes, splashes, sprays, splatters, speckles, threads, and granules.

### Claim 33 (depends on 31)

The system of claim 31 wherein the deposited random integrated optically identifiable marking is both on a surface of and within the drug unit.

### Claim 34 (depends on 31)

The system of claim 31, further comprising a comparator configured to perform an optical comparison of the selected one of the drug units and the drug unit marking data.

### Claim 35 (depends on 31)

The system of claim 31, further comprising a comparator configured to perform pattern recognition comparison of the selected one of the drug units and the drug unit marking data.

### Claim 36 (depends on 35)

The system of claim 35 wherein the comparator performs pattern recognition based upon one or more equations of lines between portions of the integrated optically identifiable marking, as a function of vector length and radius angle relative to a selected frame of reference.

### Claim 37 (depends on 31)

The system of claim 31 wherein the drug unit maerking data comprises image information based on the deposited random integrated optically identifiable marking.

### Claim 38 (depends on 31)

The system of claim 31 wherein the drug unit mareking data further comprises information associated with the secondary product identifier.

### Claim 39 (depends on 31)

The system of claim 31 wherein the secondary product identifier is a quick response code, bar code, or a radio-frequency identification system.

### Claim 40 (depends on 31)

The system of claim 31, further comprising human-readable drug unit marking data.

### Claim 41 (depends on 31)

The system of claim 31, further comprising human-readable drug unit image data.

### Claim 42 (depends on 31)

The system of claim 31 wherein the drug unit marking data comprises image data unique to a single one of the plurality of drug units based upon an image of the marking of single one of the plurality of drug units.

### Claim 43

Drug unit identification marking data uniquely identifiable to a single drug unit of a plurality of drug units having a common drug, the single drug unit having a deposited integrated optically identifiable markings, wherein the markings have a size, shape, and random location unique to the drug unit, wherein the drug unit identification marking edata comprises at least one machine readable identification data set unique to the single drug unit and associated with the markings on the drug unit indicating the size, shape, and random location of the markings for use in identifying the single drug unit based on the drug unit identification marking data.

### Claim 44 (depends on 43)

The drug unit identification marking data of claim 43 wherein the deposited integrated optically identifiable markings includes one or more of randomly distributed dots, spots, shapes, splashes, sprays, splatters, speckles, threads, and granules.

### Claim 45 (depends on 43)

The drug unit identification marking data of claim 43 wherein the image data comprises information associated with a secondary product identifier common to a plurality of the drug units and related to a common drug of the plurality of drug units.

### Claim 46 (depends on 43)

The drug unit identification marking data of claim 43 wherein the image data comprises information associated with drug unit production details.

### Claim 47 (depends on 43)

The drug unit identification marking data of claim 43 wherein the drug unit identification marking data comprises image data unique to the single drug unit and associated with the markings on the drug unit.

### Claim 48

A uniquely identifiable single drug unit product comprising a drug unit with deposited random integrated optically identifiable markings having a size, shape, and random location or distribution unique to the drug unit, wherein the identifiable marking are configured to identify the single drug unit and differentiate the single drug unit from any other drug units.

### Claim 49 (depends on 48)

The product of claim 48, further comprising a secondary product identifier common to a plurality of other drug units.

### Claim 50 (depends on 48)

The product of claim 48, further comprising a secondary product identifier located on a removable component associated with the drug unit.

### Claim 51 (depends on 48)

The product of claim 48 wherein the deposited random integrated optically identifiable marking is on a surface of or within the drug unit.
